Gossamer Bio, Inc. (GOSS) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Gossamer Bio, Inc. (GOSS) Bundle
Enhance your investment strategies with the Gossamer Bio, Inc. (GOSS) DCF Calculator! Obtain authentic financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Gossamer Bio, Inc. (GOSS).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -186.1 | -234.0 | -209.3 | -211.1 | -172.2 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | 3.1 | 4.3 | 5.2 | 4.4 | 1.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -189.2 | -238.2 | -214.5 | -215.5 | -173.8 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 401.8 | 512.6 | 325.2 | 255.7 | 296.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | -1.5 | .4 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 1.0 | 7.5 | 3.2 | 1.5 | 5.5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -6.6 | -24.9 | -1.6 | -.5 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -189.8 | -246.3 | -228.3 | -225.7 | -173.8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -190.8 | -262.2 | -228.5 | -223.7 | -168.1 | -5.5 | .0 | .0 | .0 | .0 |
| WACC, % | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 | 9.15 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -5.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -5 | |||||||||
| Net Debt | 180 | |||||||||
| Equity Value | -185 | |||||||||
| Diluted Shares Outstanding, MM | 153 | |||||||||
| Equity Value Per Share | -1.21 |
What You Will Get
- Real GOSS Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Gossamer Bio’s future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Gossamer Bio, Inc. (GOSS).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to GOSS.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates for Gossamer Bio, Inc. (GOSS).
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Gossamer Bio, Inc. (GOSS).
- Visual Dashboard and Charts: Graphical representations summarize essential valuation metrics for straightforward analysis of GOSS.
How It Works
- Step 1: Download the Excel file for Gossamer Bio, Inc. (GOSS).
- Step 2: Review Gossamer Bio's pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose This Calculator for Gossamer Bio, Inc. (GOSS)?
- All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for Gossamer Bio.
- Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Gossamer Bio’s intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable starting points for analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and business advisors focusing on Gossamer Bio.
Who Should Use This Product?
- Investors: Evaluate Gossamer Bio’s valuation prior to making stock transactions.
- CFOs and Financial Analysts: Enhance the efficiency of valuation processes and validate forecasts.
- Startup Founders: Understand the valuation methods of prominent biotech companies like Gossamer Bio.
- Consultants: Provide detailed valuation reports to clients in the biotech sector.
- Students and Educators: Utilize real-world examples to teach and practice valuation methodologies.
What the Template Contains
- Pre-Filled Data: Includes Gossamer Bio’s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Gossamer Bio’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.